1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid, 10-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-, calcium salt (1:1),rel- (151878-23-8)

Identification
Name:	1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid, 10-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-, calcium salt (1:1),rel-
CAS:	151878-23-8
Molecular Formula:	C18H34 N4 O9 . Ca
Molecular Weight:	488.5461
InChI:	InChI=1/C18H34N4O9.Ca/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+2/p-2
Molecular Structure:
Properties
Flash Point:	400.4°C
Boiling Point:	738.5°C at 760 mmHg
Flash Point:	400.4°C
Safety Data

Other Product

rel-10-[(1R,2S)-2,3-Dihydroxy-1-(hydroxyMethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic Acid
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid,10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-
Gadolinium,[10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-
2H-1,4-Benzodiazepin-2-one,7-chloro-1,3- dihydro-1-methyl-5-phenyl-,mixt. with 10-[3-(4-methyl-1-piperazinyl)propyl]-2- (trifluoromethyl)-10H-phenothiazine dihydrochloride and (1R,2S)-rel-2-phenylcyclopropanamine sulfate (2:1)
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-
3-Pentene-1,2-diol,1-[(1'aR,2S,2''R,3'aR,4'R,7'aS,10'aS)-4'-(acetyloxy)-1'a,3'a,7'a,8',9',10'a-hexahydrodispiro[oxirane-2,3'(2'H)-oxireno[6,7]cyclonona[1,2-c]pyran-10'(4'H),2''-oxiran]-7'-yl]-4-methyl-,1,2-diacetate, (1R,2S)-rel-(+)-
Copper(2+), (1,4,7,10-tetramethyl-1,4,7,10-tetraazacyclododecane-N(sup 1),N(sup 4), N(sup 7),N(sup 10))-, dichloride
1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid, 10-[(4-aminophenyl)methyl]-
Calciate(1-),[10-[2-(hydroxy-kO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-, calcium (2:1) (9CI)
1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid, 10-(2-hydroxypropyl)-
10-Undecenoic acid,calcium salt (2:1)
3,6-Cyclodecadiene-1,2-diol,10-[(1R)-1,5-dimethyl-4-hexen-1-yl]-3-(hydroxymethyl)-7-methyl-,(1S,2R,3E,6E,10R)-rel-(-)-
Spiro[oxirane-2,1'(2'H)-phenanthren]-2'-one,7'-ethenyl-4'a,4'b,5',6',7',8',8'a,9',10',10'adecahydro- 3',10'-dihydroxy-4'b,7',10'atrimethyl-,(1'R,4'aR,4'bS,7'S,8'aR,10'R,10'aR)- rel-
2(1H)-Pyrimidinone,1-[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]-4-(dimethylamino)-,rel-
(2Z)-2-[(1R,2S,5S,6R,10S)-1,10-dihydroxy-2-[(1E,3E)-1-(hydroxymethyl)-9-methyl-5-methylidenedeca-1,3,8-trien-1-yl]-6-(3-hydroxypropyl)-10-methylspiro[4.5]dec-7-ylidene]propanal
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)-one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3-[(2S,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]propyl]-7'-(b-D-glucopyranosyloxy)dodecahydro-4'b,8',8',10'a-tetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,10'aR)-
2H-1-Benzopyran-2-one,8-[(1R,2S)-1,2-dihydroxy-3-methylbutyl]-7-methoxy-, rel-(-)-
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; (1R,2S)-2-phenylcyclopropan-1-amine; sulfuric acid; dihydrochloride
Spiro[furan-2(3H),7'-[7H-3]oxacyclopenta[5,6]cycloocta[1,2,3-cd]pentalen]-4'(1'H)-one,2',2'a,4,5,6',6'a,8',9',9'a,10',10'a,10'b-dodecahydro-1',2'a-dihydroxy-1',3,9'a-trimethyl-5-(2-methyl-1-propen-1-yl)-,(1'R,2S,3S,6'aR,9'aR,10'aS,10'bR)-
1H-Naphtho[2,3-c]pyran-6,9-dione,10-hydroxy-8-[(2R,4S,5R)-5-hydroxy-4-(hydroxymethyl)-1,3-dioxan-2-yl]-3-methyl-7-(2-oxopropyl)-1-propyl-,rel-